» Articles » PMID: 18278519

The Neurogenic Bladder: Introducing Four Contributions

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2008 Feb 19
PMID 18278519
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Neurogenic bladder dysfunction in children is frequently seen in patients with meningomyelocele (MMC). The disorder carries a high risk for all kinds of complications, with renal damage being the most important. More than 95% of MMC patients have a neurogenic bladder, the paramount manifestation of which is a disturbed coordination between detrusor and sphincter muscles. This vesicourethral dysfunction leads to defective filling and emptying of the urinary bladder. Voiding at will is almost never possible. According to the location and extent of the neural tube lesion, patients have either an atonic or a hypertonic pelvic floor and either an atonic or a hypertonic detrusor, leading to four classic combinations. Hypertonic sphincter and detrusor hyperactivity lead to the most dangerous form of neurogenic bladder, referred to as the "unsafe" bladder. The presence of residual urine in a high-pressure container causes either decompensation of the detrusor with vesicoureteral reflux or deterioration of the bladder wall with hypertrophy and stiffness resulting in uterovesical obstruction. The subsequent insufficient drainage of the upper urinary tract leads to decompensation of the ureters and finally to chronic renal disease, the process being accelerated by urinary tract infections. The aim of treatment is to restore as much as possible both essential functions: urine storage and timely emptying of the reservoir. What should and can be achieved is a more or less adequate, low-pressure, functional capacity of the bladder that is emptied as completely as possible by clean intermittent catheterization (CIC). MMC leads to the prototype of neurogenic bladder in childhood. What we know and what we do for MMC patients can roughly be applied to all other forms of neurogenic bladder, either congenital or acquired.

Citing Articles

Voiding dysfunction in children causes, management, and prognosis: A single-center retrospective study.

El Desoky S, Banakhar M, Khashoggi K, Zaher Z, Kari J Saudi Med J. 2021; 42(8):869-877.

PMID: 34344811 PMC: 9195553. DOI: 10.15537/smj.2021.42.8.20210327.


Intradetrusor injection of botulinum toxin A in children: a 10-year single centre experience.

Peeraully R, Lam C, Mediratta N, Patel R, Williams A, Shenoy M Int Urol Nephrol. 2019; 51(8):1321-1327.

PMID: 31183660 DOI: 10.1007/s11255-019-02185-3.


Do current bladder smooth muscle cell isolation procedures result in a homogeneous cell population? Implications for bladder tissue engineering.

Sharma A, Donovan J, Hagerty J, Sullivan R, Edassery S, Harrington D World J Urol. 2009; 27(5):687-94.

PMID: 19234706 DOI: 10.1007/s00345-009-0391-3.

References
1.
Schurch B, Corcos J . Botulinum toxin injections for paediatric incontinence. Curr Opin Urol. 2005; 15(4):264-7. DOI: 10.1097/01.mou.0000172401.92761.86. View

2.
de Kort L, Nesselaar C, van Gool J, de Jong T . The influence of colonic enema irrigation on urodynamic findings in patients with neurogenic bladder dysfunction. Br J Urol. 1997; 80(5):731-3. DOI: 10.1046/j.1464-410x.1997.00435.x. View

3.
de Jong T, Chrzan R, Klijn A, Dik P . Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol. 2008; 23(6):889-96. PMC: 2335291. DOI: 10.1007/s00467-008-0780-7. View

4.
Boemers T, van Gool J, de Jong T, Bax K . Lower urinary tract dysfunction in children with benign sacrococcygeal teratoma. J Urol. 1994; 151(1):174-6. DOI: 10.1016/s0022-5347(17)34909-1. View

5.
Metcalfe P, Luerssen T, King S, Kaefer M, Meldrum K, Cain M . Treatment of the occult tethered spinal cord for neuropathic bladder: results of sectioning the filum terminale. J Urol. 2006; 176(4 Pt 2):1826-9. DOI: 10.1016/j.juro.2006.04.090. View